Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Recruiting · NCT04875702 · Registry updated 2025-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Recruiting | Phase 4 | 2025-09-25 | NCT04875702 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 108 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Medical Center (BMC) | Boston | United States | 1 |
| Brigham and Women's Hospital (BWH) | Boston | United States | 3 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| NYU Langone | New York | United States | 3 |
| The University of Alabama at Birmingham | South Birmingham | United States | 1 |
| UCLA Health | Santa Monica | United States | 1 |
| West Virginia University (Including Mobile Clinical Trials Unit) | Morgantown | United States | 1 |